Secondaries announced 7.8.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Anthera Pharmaceuticals Symbol: ANTH Price: Last trade $8.32 Trade Date: 7/9 Shares: 3 million Underwriter(s) Citigroup, Piper Jaffray Rating=Subscription Needed
